Trial intelligence / Profile preview

Phase IIa trial of Xiaotong aerosol for acute ankle sprain

ChiCTR1900026496Phase 2Not yet recruiting

Sponsor
中国中医科学院望京医院
Start
Mar 2019
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 2, open-label trial of xiaotong in Ankle sprain and musculoskeletal trauma (3 arms), sponsored by 中国中医科学院望京医院. Primary endpoint: Pain Visual Analogue Scale score at Day 7. Planned start Mar 2019; status: not yet recruiting.

02

Drugs

xiaotong
03

Conditions

Ankle sprainmusculoskeletal trauma

Beyond the preview

Go deeper on ChiCTR1900026496.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026496.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call